Cannabis as Medicine

Medical Cannabis May Reduce Cancer Immunotherapy Effectiveness, Study Warns

Growing evidence suggests that cannabis immunotherapy risks may significantly compromise cancer treatment outcomes, according to a comprehensive new review by Australian medical cannabis advocate Dr Ben Jansen. Furthermore, his research poses a critical question that could reshape patient care protocols: “Are cannabinoids with cancer immunotherapy contributing to early death?” Subsequently, Dr Jansen’s newly published study

Medical Cannabis May Reduce Cancer Immunotherapy Effectiveness, Study Warns Read More »

Cannabis Use Linked to Rising Cancer Rates in Young Adults Across US and Canada

  A major new study has uncovered a deeply concerning connection between cannabis use and dramatically rising cancer rates amongst adolescents and young adults (AYAs) in North America. This comprehensive study, analysing data from 2000 to 2019, provides compelling evidence that cannabis exposure may be accelerating breast and testicular cancer incidence in young people at

Cannabis Use Linked to Rising Cancer Rates in Young Adults Across US and Canada Read More »

New FDA Study Exposes CBD Liver Damage at Consumer Doses

A groundbreaking clinical trial published in JAMA Internal Medicine has revealed alarming evidence of CBD liver damage in healthy adults taking doses commonly used by consumers. The US Food and Drug Administration conducted the study, challenging the widespread perception that cannabidiol products are entirely safe and highlighting significant health risks that were previously unrecognised. CBD

New FDA Study Exposes CBD Liver Damage at Consumer Doses Read More »

Cannabis and Sleep – Insomnia, Placebo & Collateral Health Harms?

The landscape of cannabis and sleep research presents a troubling pattern that has persisted for decades. A regular feature of almost all research reviews, studies and trials on cannabis invariably land with two consistent themes and/or caveats: 1) No conclusive evidence as to the claims, but possible… and 2) More research needed! This pattern is

Cannabis and Sleep – Insomnia, Placebo & Collateral Health Harms? Read More »

Australia’s Medicinal Cannabis Crisis: A System in Free Fall

  How regulatory capture, commercial greed, and political cowardice created a cannabis prescription mill masquerading as healthcare Australia’s medicinal cannabis system stands as a damning indictment of what happens when politics trumps science, profit overrides patient safety, and regulatory agencies abandon their fundamental duty to protect public health. What began in 2016 as a compassionate

Australia’s Medicinal Cannabis Crisis: A System in Free Fall Read More »

Non-Pharmaceutical Grade CBD passed off as ‘Medicinal Cannabis’ & Liver Damage

Cannabidiol (CBD) and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial Conclusions: In this randomized double-blind clinical trial of healthy adults administered CBD, 5mg/kg/d for 28 days, 8 (5.6%) experienced liver enzyme level elevations and 7 (4.9%) met protocol defined criteria for potential DILI. This research has important implications for consumer safety. The

Non-Pharmaceutical Grade CBD passed off as ‘Medicinal Cannabis’ & Liver Damage Read More »

Harvard Experts Expose Political Motives Behind Cannabis Rescheduling Push

Landmark JAMA Psychiatry study demolished scientific case for downgrading marijuana’s legal status A devastating analysis published in JAMA Psychiatry tore apart the Biden administration’s case for cannabis rescheduling, revealing how political pressure trumped scientific rigour in one of America’s most consequential drug policy decisions. The comprehensive report, authored by Harvard Medical School’s Dr Bertha Madras and Heritage

Harvard Experts Expose Political Motives Behind Cannabis Rescheduling Push Read More »

The Cannabis Con: How Australia’s Industry Became a Profit-Driven Prescription Mill

A System Built on Sentiment, Not Science: What began as a compassionate response to desperate families seeking relief for children with epilepsy has morphed into what critics aptly describe as “a commercial monster” – a barely regulated medicinal cannabis industry where doctors write cannabis prescriptions every four minutes and patients receive “Chernobyl-strength” products after brief

The Cannabis Con: How Australia’s Industry Became a Profit-Driven Prescription Mill Read More »

Bus Driver Cannabis Death Case Highlights the Risks of Drug-Driving

A tragic accident in Bexleyheath has shed new light on drug-driving risks as a bus driver, Martin Asolo-Agogua, pleaded guilty to causing the death of nine-year-old Ada Bicakci. The Bus driver cannabis death occurred when the driver, high on cannabis, struck Ada and her brother on Watling Street on the 3rd of August 2023. The heartbreaking incident

Bus Driver Cannabis Death Case Highlights the Risks of Drug-Driving Read More »

Scroll to Top